ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $0 | -100.0% | 200 | -88.2% | 0.00% | -100.0% |
Q4 2022 | $10 | -99.9% | 1,700 | -22.7% | 0.00% | 0.0% |
Q3 2022 | $14,000 | -94.0% | 2,200 | -90.0% | 0.00% | -93.8% |
Q2 2022 | $235,000 | -53.2% | 21,908 | -48.0% | 0.02% | -38.5% |
Q1 2022 | $502,000 | +148.5% | 42,156 | +81.6% | 0.03% | +225.0% |
Q4 2021 | $202,000 | +215.6% | 23,218 | +127.9% | 0.01% | +166.7% |
Q3 2021 | $64,000 | -52.2% | 10,187 | +107.9% | 0.00% | -57.1% |
Q2 2021 | $134,000 | +54.0% | 4,900 | -4.6% | 0.01% | +75.0% |
Q1 2021 | $87,000 | -89.7% | 5,134 | -86.5% | 0.00% | -90.2% |
Q4 2020 | $848,000 | +87.6% | 37,900 | +4.7% | 0.04% | +51.9% |
Q3 2020 | $452,000 | +35.7% | 36,202 | +13.4% | 0.03% | +22.7% |
Q2 2020 | $333,000 | +1565.0% | 31,938 | +930.3% | 0.02% | +2100.0% |
Q1 2020 | $20,000 | +53.8% | 3,100 | +40.9% | 0.00% | 0.0% |
Q4 2019 | $13,000 | +62.5% | 2,200 | +175.0% | 0.00% | 0.0% |
Q3 2019 | $8,000 | 0.0% | 800 | -11.1% | 0.00% | 0.0% |
Q2 2019 | $8,000 | – | 900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
Diametric Capital, LP | 26,130 | $667,621 | 0.28% |